NeuCyte
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
NeuCyte is an early-stage biotechnology company aiming to improve how drug candidates are discovered and advanced. It uses human neural cell-based platforms for target identification and lead optimization, seeking to accelerate the early stages of drug development. The platform enables evaluation of human-specific neural phenotypes that are not observable in traditional animal models, potentially yielding more reliable indications of efficacy and neurotoxicity. Based in Mountain View, California, NeuCyte operates with a small team supported by a scientific advisory board of leading stem cell biologists and neuroscientists. It has established research collaborations to apply its neural platform to neurological disorders, including partnerships with KIF1A.ORG and the Seaver Autism Center for Research and Treatment at Icahn School of Medicine at Mount Sinai, along with a license agreement with Boston Children's Hospital.
1-888-653-2347 
support@leadiq.com 
